Marco Tartaglia Selected Research

Neuroblastoma

4/2006	Activating PTPN11 mutations play a minor role in pediatric and adult solid tumors.
5/2005	Rat nicastrin gene: cDNA isolation, mRNA variants and expression pattern analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marco Tartaglia Research Topics

Disease

37	Noonan Syndrome (Female Pseudo-Turner Syndrome) 01/2023 - 10/2002
26	Neoplasms (Cancer) 04/2024 - 04/2006
11	Intellectual Disability (Idiocy) 01/2023 - 10/2016
9	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 10/2016
8	Neurodevelopmental Disorders 03/2024 - 01/2019
8	Inborn Genetic Diseases (Disease, Hereditary) 11/2023 - 09/2011
7	LEOPARD Syndrome (Syndrome, LEOPARD) 01/2021 - 02/2006
6	Carcinogenesis 04/2024 - 10/2015
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024 - 03/2009
5	Epilepsy (Aura) 11/2023 - 01/2016
5	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2022 - 03/2011
5	Colorectal Neoplasms (Colorectal Cancer) 12/2018 - 11/2008
4	Muscle Hypotonia (Hypotonia) 01/2023 - 04/2016
4	Congenital Heart Defects (Congenital Heart Defect) 01/2022 - 09/2004
4	Deafness (Deaf Mutism) 11/2021 - 06/2010
4	Mitochondrial Diseases (Mitochondrial Disease) 12/2020 - 01/2017
4	Brain Diseases (Brain Disorder) 01/2020 - 04/2016
3	Lymphoma (Lymphomas) 04/2024 - 08/2015
3	Microcephaly 11/2022 - 01/2016
3	Ataxia (Dyssynergia) 09/2022 - 01/2018
3	Seizures (Absence Seizure) 01/2022 - 04/2016
3	Megalencephaly 01/2021 - 01/2018
3	Atrophy 01/2020 - 04/2016
3	Leukemia 09/2011 - 02/2006
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 04/2024 - 06/2011
2	Brain Neoplasms (Brain Tumor) 04/2024 - 01/2021
2	Glioblastoma (Glioblastoma Multiforme) 02/2024 - 01/2021
2	Neurofibroma 01/2024 - 08/2015
2	Cardiofaciocutaneous syndrome 11/2023 - 01/2021
2	Autism Spectrum Disorder 11/2023 - 01/2019
2	Melanoma (Melanoma, Malignant) 09/2023 - 04/2006
2	Hypersensitivity (Allergy) 01/2023 - 04/2010
2	Reinfection 01/2023 - 01/2022
2	Infections 01/2023 - 01/2022
2	Ciliopathies 01/2023 - 11/2022
2	Autistic Disorder (Autism) 01/2023 - 01/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 11/2021
2	Ependymoma 01/2022 - 11/2017
2	Movement Disorders (Movement Disorder) 01/2022 - 01/2019
2	Cardiomyopathies (Cardiomyopathy) 11/2021 - 07/2015
2	Rare Diseases (Rare Disease) 11/2021 - 01/2021
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 11/2021 - 11/2019
2	Glioma (Gliomas) 05/2021 - 04/2006
2	Facies 01/2021 - 01/2019
2	Optic Atrophy 01/2020 - 10/2016
2	Parkinsonian Disorders (Parkinsonism) 01/2020 - 01/2019
2	Cognitive Dysfunction 11/2019 - 01/2019
2	Atrioventricular Septal Defect 10/2018 - 02/2013
2	Heart Failure 04/2018 - 06/2014
2	Costello Syndrome 01/2017 - 03/2010

Drug/Important Bio-Agent (IBA)

33	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2003
11	Mitogen-Activated Protein KinasesIBA 12/2022 - 10/2006
9	Protein Tyrosine PhosphatasesIBA 01/2022 - 10/2002
6	Transcription Factors (Transcription Factor)IBA 02/2024 - 04/2006
5	Protein Isoforms (Isoforms)IBA 11/2021 - 05/2005
5	Phosphoric Monoester Hydrolases (Phosphatases)IBA 05/2012 - 03/2004
4	Phosphotransferases (Kinase)IBA 04/2024 - 04/2009
4	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 06/2017
4	Riboflavin (Vitamin B2)FDA LinkGeneric 06/2022 - 01/2020
4	EnzymesIBA 01/2022 - 01/2016
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021 - 06/2009
3	Histones (Histone)IBA 09/2023 - 01/2019
3	RNA (Ribonucleic Acid)IBA 09/2023 - 10/2020
3	NucleotidesIBA 01/2023 - 12/2017
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2023 - 08/2007
3	PotassiumIBA 08/2022 - 10/2018
3	Growth Hormone (Somatotropin)IBA 01/2022 - 11/2015
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2021 - 08/2010
3	Neurofibromin 1 (Neurofibromin)IBA 11/2021 - 08/2015
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 09/2009
3	TubulinIBA 01/2018 - 10/2016
3	GTP Phosphohydrolases (GTPases)IBA 01/2017 - 03/2010
2	tyrosine receptor (receptor, tyrosine)IBA 04/2024 - 05/2012
2	Lysine (L-Lysine)FDA Link 03/2024 - 11/2021
2	MethyltransferasesIBA 03/2024 - 11/2021
2	UbiquitinIBA 06/2023 - 11/2021
2	Ligases (Synthetase)IBA 06/2023 - 08/2015
2	LipidsIBA 01/2023 - 08/2015
2	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 01/2016
2	KinesinsIBA 01/2023 - 01/2018
2	ElementsIBA 11/2022 - 10/2020
2	ChromatinIBA 10/2022 - 01/2019
2	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 11/2021
2	TAE226IBA 01/2022 - 11/2021
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2022 - 11/2021
2	MitogensIBA 01/2022 - 11/2017
2	Protein Kinases (Protein Kinase)IBA 01/2022 - 01/2020
2	CollagenIBA 12/2021 - 11/2017
2	Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA 11/2021 - 03/2011
2	Potassium Channels (Potassium Channel)IBA 06/2021 - 09/2020
2	Everolimus FDA Link 05/2021 - 08/2020
2	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2021 - 01/2007
2	Monomeric GTP-Binding ProteinsIBA 01/2021 - 01/2018
2	CytokinesIBA 01/2021 - 01/2019
2	SH2 Domain-Containing Protein Tyrosine PhosphatasesIBA 01/2021 - 01/2017
2	CalcineurinIBA 10/2018 - 07/2011
2	Epidermal Growth Factor (EGF)IBA 11/2017 - 03/2004

Therapy/Procedure

16	Therapeutics 04/2024 - 04/2010
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2023 - 01/2022
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2021